-
Statins are now well established as powerful and favorable lipid-modifying drugs. They are primarily used for individuals with coronary artery disease or an abnormal lipid panel, and result in major decreases in morbidity and mortality.
-
This paper details mortality results after ventricular tachycardia (VT) ablation from one of the larger VT ablation sites in the United States, the University of Pennsylvania.
-
Catheter ablation for atrial fibrillation (AF) was first proposed over fifteen years ago but, until recently, there have been no FDA-approved devices specifically labeled for the treatment of AF.
-
Stress-induced apical cardiomyopathy (Tako-Tsubo) is a recently recognized reversible form of acute cardiomyopathy that may mimic acute myocardial infarction initially.
-
Coronary artery bypass surgery (CABG) has long been the preferred revascularization strategy for diabetic patients, but recent advances in technology have resulted in improved outcomes following percutaneous coronary intervention (PCI).
-
Two oral medications for relapsing-remitting MS in phase III development; antihypertensives find new uses; Ginkgo biloba does not prevent cognitive decline in elderly; and FDA Actions.
-
-
Cardiac surgery carries greater risk in older patients. Nonagenarians are a growing part of cardiology practice as our population ages.
-
JUPITER, a trial first presented november 9, 2008, at the american Heart Association meeting in New Orleans, was clearly "the bell of the ball," with multiple television, newspaper, and medical journal reports.
-
The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.
